Willis C. Lee - 30 May 2025 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Reporting relationship: CEO, Director
Issuer ticker: EMMA
Reported as of: 30 May 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Sep 2026, 15:05:38 UTC
Prior SEC filing: 29 Feb 2024
Source filing: View source filing
Reporting owner signature: Willis C. Lee

Key filing fact

Willis C. Lee filed Form 4 for Emmaus Life Sciences, Inc. (EMMA) on 02 Sep 2026.

Key facts

This page summarizes Willis C. Lee's Form 4 filing for Emmaus Life Sciences, Inc. (EMMA).
6 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 02 Sep 2026, 15:05.

Change

Previous filing in this sequence was filed on 29 Feb 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001517775 Primary reporting owner

LEE WILLIS C

Relationship: CEO, Director
Address: 21250 HAWTHORNE BLVD., SUITE 800, TORRANCE
Signature: Willis C. Lee
Signature date: 02 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

EMMA transaction

Common stock, $0.001 par value

Purchase

Transaction value
Shares: +70,000
Change %: +44%
Price: $0.0200^*
Shares after: 229,400
Date: 30 May 2025
Ownership: Fidelity Roth IRA FBO Willis C. Lee
Footnotes: F1

EMMA transaction

Common stock, $0.001 par value

Purchase

Transaction value
Shares: +170,000
Change %: +161%
Price: $0.0100^*
Shares after: 275,400
Date: 29 Aug 2025
Ownership: Fidelity Roth IRA FBO Willis C. Lee
Footnotes: F2

EMMA transaction

Common stock, $0.001 par value

Purchase

Transaction value
Shares: +46,000
Change %: +12%
Price: $0.0400^*
Shares after: 445,400
Date: 25 Aug 2026
Ownership: Fidelity Roth IRA FBO Willis C. Lee
Footnotes: F3

EMMA transaction

Common stock, $0.001 par value

Purchase

Transaction value
Shares: +50,000
Change %: +11%
Price: $0.0500^*
Shares after: 495,400
Date: 27 Aug 2026
Ownership: Fidelity Roth IRA FBO Willis C. Lee
Footnotes: F4

EMMA transaction

Common stock, $0.001 par value

Purchase

Transaction value
Shares: +94,767
Change %: +19%
Price: $0.0600^*
Shares after: 590,167
Date: 28 Aug 2026
Ownership: Fidelity Roth IRA FBO Willis C. Lee
Footnotes: F5

EMMA transaction

Common stock, $0.001 par value

Purchase

Transaction value
Shares: +100,000
Change %: +17%
Price: $0.0500^*
Shares after: 690,167
Date: 31 Aug 2026
Ownership: Fidelity Roth IRA FBO Willis C. Lee
Footnotes: F6

EMMA holding

Common stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 395,124
Date: 30 May 2025
Ownership: Direct

EMMA holding

Common stock, $0.001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 241,194
Date: 30 May 2025
Ownership: Fidelity Traditional IRA FBO Willis C. Leeee

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 6 footnotes

Footnote F1

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1), footnote (2), footnote (3), footnote (4), footnote (5) and footnote (6).

Footnote F2

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive.

Footnote F3

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive.

Footnote F4

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive.

Footnote F5

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive.

Footnote F6

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive.